Are there any risks or side effects
The first agent in this class was approved in 2005 for type 2 diabetes, and ongoing studies continue to look at their broader applications, long-term benefits and safety profile
Not approved or evaluated by the FDA for human use. (Regentherapy) Thus any use in humansoutside a formal clinical trialis off-label and subject to regulatory risks (depending on jurisdiction)
Supports Detoxification: By aiding liver function, glutathione assists in the removal of toxins from the body, promoting better health
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification
Kim JS, Kim J, Kim Y, Yang M, Jang H, Kang S, Kim JC, Kim SH, Shin T, Moon C